| Clyde Dale Elliott, MD | |
|
1022 1st St N, Suite 500, Alabaster, AL 35007-8706 | |
| (205) 663-5775 | |
| (205) 664-2112 |
| Full Name | Clyde Dale Elliott |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Cardiovascular Disease |
| Location | 1022 1st St N, Alabaster, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124005673 | NPI | - | NPPES |
| 051552706 | Medicaid | AL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 6974 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Clyde Dale Elliott, MD 1022 1st St N, Suite 500, Alabaster, AL 35007-8706 Ph: (205) 663-5775 | Clyde Dale Elliott, MD 1022 1st St N, Suite 500, Alabaster, AL 35007-8706 Ph: (205) 663-5775 |
News Archive
Micromet, Inc. announced today that it has entered into a collaboration agreement with Amgen Inc. for the research of BiTE antibodies against three undisclosed solid tumor targets.
DaVita Clinical Research (DCR), a specialty contract research organization with services spanning a broad spectrum of drug and device development, today announced an expansion of its clinical trials capabilities in Europe.
In a large population-based study of randomly selected participants in Germany, researchers found that mild cognitive impairment (MCI) occurred significantly more often in individuals diagnosed with a lower ankle brachial index (ABI), which is a marker of generalized atherosclerosis and thus cumulative exposure to cardiovascular risk factors during lifetime.
Every year, nearly one in four Europeans - a total of almost one million people - dies from cancer, giving Europe the dubious distinction of having amongst the highest cancer-related mortality rates in the world. Even as cancer remains a difficult disease to diagnose, often resulting in either poor diagnosis or misdiagnosis, the number of new cancer cases is set to double by 2020.
Researchers from the FEMSA Center of Biotechnology at Technologic of Monterrey (ITESM) designed a technology that uses grated carrot to obtain phenolic compounds that have a potential to prevent cancer, and cardiovascular and neurodegenerative diseases.
› Verified 6 days ago
Neeraj Mehta, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1022 1st St N Ste 500, Alabaster, AL 35007 Phone: 205-663-5775 Fax: 205-664-2112 | |
Nopporn Unnoppet, DO Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1010 1st Street North, Ste 210, Alabaster, AL 35007 Phone: 205-620-8676 Fax: 205-620-8673 | |
Brian Andrew Brunson, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1022 1st St N Ste 220, Alabaster, AL 35007 Phone: 205-663-1023 Fax: 205-802-7778 | |
Mark Lee Mullens, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1022 1st St N, Suite 500, Alabaster, AL 35007 Phone: 205-663-5775 Fax: 205-664-2112 | |
Dr. James Warren Evans, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1024 1st St N, Alabaster, AL 35007 Phone: 205-664-4051 | |
Bradley A Rubery, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1010 1st St N, Suite 112, Alabaster, AL 35007 Phone: 205-663-1023 Fax: 205-802-7778 |